Accumulated Depreciation
Pfizer Accumulated Depreciation increased by 1.2% to $71.34B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.3%, from $66.50B to $71.34B. Over 4 years (FY 2020 to FY 2024), Accumulated Depreciation shows an upward trend with a 2.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
A rising balance relative to gross assets suggests an aging infrastructure, potentially signaling a need for future capital expenditure to replace equipment.
Detailed definition
This is the cumulative amount of depreciation expense charged against the company's tangible assets since their acquisit...
Peer comparison
Commonly found in the balance sheet or notes for all companies with significant physical property, plant, and equipment.
ppe_accumulated_depreciationHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $54.79B | $55.54B | $15.07B | $56.54B | $57.08B | $57.51B | $15.17B | $59.17B | $60.37B | $61.46B | $16.05B | $64.15B | $65.37B | $66.50B | $16.48B | $68.78B | $70.52B | $71.34B |
| QoQ Change | — | +1.4% | -72.9% | +275.1% | +0.9% | +0.8% | -73.6% | +290.0% | +2.0% | +1.8% | -73.9% | +299.8% | +1.9% | +1.7% | -75.2% | +317.3% | +2.5% | +1.2% |
| YoY Change | — | — | — | — | +4.2% | +3.5% | +0.7% | +4.7% | +5.8% | +6.9% | +5.7% | +8.4% | +8.3% | +8.2% | +2.7% | +7.2% | +7.9% | +7.3% |
| % of PP&E (Net) | 385.2% | 384.8% | 101.3% | 374.2% | 374.4% | 372.5% | 93.2% | 347.0% | 345.2% | 344.1% | 84.7% | 341.2% | 344.8% | 358.7% | 89.6% | 374.9% | 375.6% | 377.8% |
| Share Change | — | -0.5pp | -283.5pp | +272.9pp | +0.2pp | -2.0pp | -279.2pp | +253.8pp | -1.8pp | -1.1pp | -259.4pp | +256.4pp | +3.7pp | +13.9pp | -269.1pp | +285.3pp | +0.7pp | +2.2pp |
Accumulated Depreciation at Other Companies
Frequently Asked Questions
- What is Pfizer's accumulated depreciation?
- Pfizer (PFE) reported accumulated depreciation of $71.34B in Q3 2025.
- How has Pfizer's accumulated depreciation changed year-over-year?
- Pfizer's accumulated depreciation increased by 7.3% year-over-year, from $66.50B to $71.34B.
- What is the long-term trend for Pfizer's accumulated depreciation?
- Over 4 years (2020 to 2024), Pfizer's accumulated depreciation has grown at a 2.7% compound annual growth rate (CAGR), from $14.81B to $16.48B.
- What does accumulated depreciation mean?
- The total amount of depreciation recorded against physical assets over time.